This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Yuhan Corporation. Active years: 2021-2023.
Company Filing History:
Years Active: 2021-2023
Title: Eui Chul Lee: Innovator in Pharmaceutical Compositions
Introduction
Eui Chul Lee is a notable inventor based in Yongin-si, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of three patents to his name, Lee's work focuses on compounds that exhibit therapeutic potential.
Latest Patents
Lee's latest patents include the development of 3,3-difluoroallylamines or salts thereof, along with pharmaceutical compositions that incorporate these compounds. The technology he has developed provides methods for preparing these compounds and highlights their uses in treating conditions such as nonalcoholic hepatosteatosis (NASH). The 3,3-difluoroallylamines and their pharmaceutically acceptable salts demonstrate potent inhibitory activity on VAP-1, making them valuable in medical applications.
Career Highlights
Eui Chul Lee is currently associated with Yuhan Corporation, a leading pharmaceutical company in South Korea. His work at Yuhan Corporation has allowed him to focus on innovative research and development in the pharmaceutical sector. His contributions have been instrumental in advancing therapeutic options for various health conditions.
Collaborations
Lee collaborates with talented colleagues, including Tae Dong Han and Hee Jae Tak. Their combined expertise fosters a productive environment for innovation and research within the company.
Conclusion
Eui Chul Lee's work exemplifies the impact of innovation in the pharmaceutical industry. His patents not only contribute to scientific knowledge but also hold promise for improving patient care.